AGHEMO, ALESSIO MICHELE

AGHEMO, ALESSIO MICHELE  

Universita' degli Studi di MILANO  

Mostra records
Risultati 1 - 20 di 140 (tempo di esecuzione: 0.0 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
Should Artificial Intelligence-based language models be allowed in developing scientific manuscripts? A debate between ChatGPT and the editors of Liver International 2023 Aghemo, AlessioValenti, Luca + Article (author) -
Detailed stratified GWAS analysis for severe COVID-19 in four European populations 2022 Mantovani, AlbertoZanella, AlbertoBandera, AlessandraCherubini, AlessandroProtti, AlessandroAghemo, AlessioLleo, AnaGori, AndreaFracanzani, Anna LudovicaRuello, AntonellaPesenti, AntonioHu, CinziaPaccapelo, CinziaCappadona, ClaudioGalimberti, DanielaScarpini, ElioParaboschi, Elvezia MariaMartinelli-Boneschi, FilippoPeyvandi, FloraBlasi, FrancescoMalvestiti, FrancescoGrasselli, GiacomoCostantino, GiorgioBaselli, GuidoTerranova, LeonardoCarrabba, MariaMiozzo, MonicaMontano, NicolaPreatoni, PaolettaBonfanti, PaoloGualtierotti, RobertaPelusi, SerenaBosari, SilvanoAliberti, StefanoRimoldi, ValeriaDuga, StefanoAsselta, RosannaValenti, Luca + Article (author) -
Dysmetabolism, Diabetes and Clinical Outcomes in Patients Cured of Chronic Hepatitis C: A Real-Life Cohort Study 2022 Valenti L.Pelusi S.Aghemo A.Pasulo L.Degasperi E.D'Ambrosio R.Zuccaro V.Giorgini A.Rumi M. G.Spinelli O.Colombo M. C.Menzaghi B.D'Arminio Monforte A.Bonfanti P.Lampertico P. + Article (author) -
COVID-19 and the liver: A 2021 update 2021 Aghemo A.Valenti L. + Article (author) -
Should individuals who have been cured of hepatitis C virus and their partners be allowed to donate blood? 2021 Aghemo A.Valenti L.Rumi M. G. + Article (author) -
High rates of sustained virological response despite premature discontinuation of directly acting antivirals in HCV-infected patients treated in a real-life setting 2021 Lombardi A.Colaneri M.D'Ambrosio R.Degasperi E.Dibenedetto C.Giorgini A.Pasulo L.Spinelli O.Re T.Rumi M.Aghemo A.Lampertico P.Soffredini R.Perbellini R.Gori A.Colpani M.Manini M.Lazzaroni S.De Nicola S.Angelini Zucchetti T.Rossotti R.Colella E.Magnani C.Mena M.Caramma I.Basilico C.Biagiotti S.Mazzone A.Saladino V.Menzaghi B.Rumi M.Fanetti I.Dibenedetto C.Zermiani P.Zuin M.D'Arminio Monforte A.Capretti A.Messina E.Colombo A. E.Bonfanti P.Conforti S.Menozzi F.Gritti S.Giani P. + Article (author) -
Is there an 'ideal' diet for patients with NAFLD? 2021 Valenti, LucaAghemo, Alessio + Article (author) -
COVID-19 and liver disease 2020 Aghemo A.Valenti L. + Article (author) -
Renal safety in 3264 HCV patients treated with DAA-based regimens : results from a large Italian real-life study 2020 Pasulo L.Giorgini A.Fanetti I.Aghemo A.Menzaghi B.Lombardi A.Spinelli O.D'Arminio Monforte A.Zuin M.Lampertico P. + Article (author) -
Comparison of three therapeutic regimens for genotype-3 hepatitis C virus infection in a large real-life multicentre cohort 2020 Lapadula G.Valsecchi M. G.Carriero C.Degasperi E.Pasulo L.Baiguera C.Menzaghi B.Lombardi A.Aghemo A.Rumi M. G.Valenti L.De Bona A.d'Arminio Monforte A.Bonfanti P.Perini P.Capretti A.Ciaccio A.Lampertico P. + Article (author) -
High rate of sustained virological response with direct-acting antivirals in haemophiliacs with HCV infection : A multicenter study 2020 Lampertico P.Peyvandi F.Aghemo A. + Article (author) -
S1pr2 is a key mediator of endoplasmic reticulum stress in NAFLD/ NASH pathogenesis 2020 Petti, LucianaLleo, AnaRestelli, SilviaDonadon, MatteoArena, VincenzoCorsetto, PaolaRizzo, Angela MariaAghemo, AlessioVetrano, Stefania + Article (author) -
High rates of 30-day mortality in patients with cirrhosis and COVID-19 2020 Triolo M.Massironi S.Aghemo A.Pedaci M.Rimondi A.Rumi M. G.Bonfanti P.Lampertico P. + Article (author) -
Genomewide Association Study of Severe Covid-19 with Respiratory Failure 2020 Baselli, GuidoAsselta, RosannaZanella, AlbertoBandera, AlessandraProtti, AlessandroAghemo, AlessioLleo, AnaGori, AndreaFracanzani, Anna LudovicaPesenti, AntonioPaccapelo, CinziaParaboschi, Elvezia M.Martinelli-Boneschi, FilippoPeyvandi, FloraBlasi, FrancescoGrasselli, GiacomoCostantino, GiorgioTerranova, LeonardoCarrabba, MariaMiozzo, MonicaMontano, NicolaSacchi, NicolettaPreatoni, PaolettaBonfanti, PaoloGualtierotti, RobertaPelusi, SerenaAliberti, StefanoRimoldi, ValeriaBosari, SilvanoDuga, StefanoValenti, Luca + Article (author) -
Treatment of 320 genotype 3 cirrhotic patients with 12 weeks Sofosbuvir/Velpatasvir with or without ribavirin: real life experience from Italy 2019 D'Ambrosio, R.Di Marco, V.Fabris, P.Lombardi, A.Zuin, M.Aghemo, A.Rumi, M. G.Spinelli, O.Colli, A.Menzaghi, B.Soffredini, R.Colpani, M.Gori, A.Giorgini, A.Capretti, A.Colombo, A. E.Dibenedetto, C.Lampertico, P. + Article (author) -
Evaluation of three “beyond Baveno VI” criteria to safely spare endoscopies in compensated advanced chronic liver disease 2019 Tosetti, GiuliaLa Mura, VincenzoD'Ambrosio, RobertaDegasperi, ElisabettaMezzina, NicolòViganò, MauroRumi, MariagraziaFracanzani, Anna LudovicaLombardi, RosaFargion, SilviaAghemo, AlessioLampertico, Pietro + Article (author) -
Rare Pathogenic Variants Predispose to Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease 2019 Pelusi S.Baselli G.Pietrelli A.Dongiovanni P.Donati B.Meroni M.Fracanzani A. L.Fargion S.Aghemo A.De Francesco R.Valenti L. V. C. + Article (author) -
JNJ-4178 (AL-335, Odalasvir, and Simeprevir) for 6 or 8 Weeks in Hepatitis C Virus-Infected Patients Without Cirrhosis : OMEGA-1 2019 Aghemo, AlessioLampertico, Pietro + Article (author) -
Real-world effectiveness and safety of glecaprevir/pibrentasvir in 723 patients with chronic hepatitis C 2019 D'Ambrosio, RobertaPasulo, LuisaGatti, FedericoMenzaghi, BarbaraRumi, Maria GraziaGiorgini, AlessiaSpinelli, OmbrettaSaladino, ValeriaBonfanti, PaoloGori, AndreaLampertico, PietroAghemo, Alessio + Article (author) -
Real life experiences in HCV management in 2018 2019 Viganò, MauroPerno, Carlo FedericoAghemo, AlessioCento, ValeriaLampertico, Pietro + Article (author) -